カリフォルニア州におけるループス腎炎の臨床試験
カリフォルニア州内の拠点で、ループス腎炎に関する15件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Ronald Reagan UCLA Medical Center, Los Angeles
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/10/01更新 · NCT05268289VIBRANT: VIB4920 for Active Lupus Nephritis
- University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology, La Jolla
- UCLA Medical Center: Division of Rheumatology, Los Angeles
- of California, Irvine School of Medicine Division of Rheumatology, Orange
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05201469Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- University of California San Francisco - Zuckerberg San Francisco General, San Francisco
被験者募集中第1相
18歳〜60歳 · 全性別 · 2026/09/14更新 · NCT06975787The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- University of California, San Francisco, San Francisco
被験者募集中第2相
8歳〜20歳 · 全性別 · 2026/09/14更新 · NCT05538208A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Wallace Rheumatic Studies Center, Beverly Hills
- Kaiser Permanente Fontana, Fontana
- Providence Medical Foundation, Fullerton
- 他2件
被験者募集中第2相
12歳〜70歳 · 全性別 · 2026/09/14更新 · NCT07570862A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, San Francisco
- Research Site, Stanford
被験者募集中第1/2相
18歳〜70歳 · 全性別 · 2026/09/10更新 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
被験者募集中第1相
18歳〜74歳 · 全性別 · 2026/09/10更新 · NCT07085104A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Loma Linda University health, Loma Linda
- UCSF Benioff Childrens Hospital, San Francisco
被験者募集中第2相
5歳〜17歳 · 全性別 · 2026/09/03更新 · NCT05039619A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- UC San Diego Health, La Jolla
- Stanford University Medical Center, Redwood City
被験者募集中第1相
18歳〜70歳 · 全性別 · 2026/08/28更新 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of California Irvine, Orange
- UC Davis Health, Sacramento
被験者募集中第1/2相
18歳〜65歳 · 全性別 · 2026/08/26更新 · NCT06121297PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Purushotham & Akther Kotha MD, Inc., La Mesa
- Valerius Medical Group & Research Center of Greater Long Beach, Inc., Los Alamitos
被験者募集中第4相
18歳〜75歳 · 全性別 · 2026/08/03更新 · NCT07611214A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, Tustin
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/06/04更新 · NCT06557265A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- 他2件
被験者募集中第1相
12歳〜70歳 · 全性別 · 2026/05/22更新 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Wallace Rheumatic Studies Center, Beverly Hills
- UCLA, Los Angeles
被験者募集中観察研究
18歳〜110歳 · 全性別 · 2026/04/15更新 · NCT05934149Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
- Lucile Packard Children's Hospital, Palo Alto
被験者募集中第1/2相
1歳〜30歳 · 全性別 · 2023/07/17更新 · NCT05508009ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。